Literature DB >> 31818949

A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism.

Marcus Davidsson1, Gang Wang1, Patrick Aldrin-Kirk1, Tiago Cardoso2, Sara Nolbrant2, Morgan Hartnor1, Janitha Mudannayake1, Malin Parmar2, Tomas Björklund3.   

Abstract

Adeno-associated virus (AAV) capsid modification enables the generation of recombinant vectors with tailored properties and tropism. Most approaches to date depend on random screening, enrichment, and serendipity. The approach explored here, called BRAVE (barcoded rational AAV vector evolution), enables efficient selection of engineered capsid structures on a large scale using only a single screening round in vivo. The approach stands in contrast to previous methods that require multiple generations of enrichment. With the BRAVE approach, each virus particle displays a peptide, derived from a protein, of known function on the AAV capsid surface, and a unique molecular barcode in the packaged genome. The sequencing of RNA-expressed barcodes from a single-generation in vivo screen allows the mapping of putative binding sequences from hundreds of proteins simultaneously. Using the BRAVE approach and hidden Markov model-based clustering, we present 25 synthetic capsid variants with refined properties, such as retrograde axonal transport in specific subtypes of neurons, as shown for both rodent and human dopaminergic neurons.
Copyright © 2019 the Author(s). Published by PNAS.

Entities:  

Keywords:  barcoding; dopamine; gene therapy; retrograde transport; vector evolution

Year:  2019        PMID: 31818949     DOI: 10.1073/pnas.1910061116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Using rAAV2-retro in rhesus macaques: Promise and caveats for circuit manipulation.

Authors:  Adriana K Cushnie; Hala G El-Nahal; Martin O Bohlen; Paul J May; Michele A Basso; Piercesare Grimaldi; Maya Zhe Wang; Marron Fernandez de Velasco Ezequiel; Marc A Sommer; Sarah R Heilbronner
Journal:  J Neurosci Methods       Date:  2020-07-12       Impact factor: 2.390

2.  Brain-wide analysis of the supraspinal connectome reveals anatomical correlates to functional recovery after spinal injury.

Authors:  Zimei Wang; Adam Romanski; Vatsal Mehra; Yunfang Wang; Matthew Brannigan; Benjamin C Campbell; Gregory A Petsko; Pantelis Tsoulfas; Murray G Blackmore
Journal:  Elife       Date:  2022-07-15       Impact factor: 8.713

Review 3.  Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders.

Authors:  Beverly L Davidson; Guangping Gao; Elizabeth Berry-Kravis; Allison M Bradbury; Carsten Bönnemann; Joseph D Buxbaum; Gavin R Corcoran; Steven J Gray; Heather Gray-Edwards; Robin J Kleiman; Adam J Shaywitz; Dan Wang; Huda Y Zoghbi; Terence R Flotte; Sitra Tauscher-Wisniewski; Cynthia J Tifft; Mustafa Sahin
Journal:  Mol Ther       Date:  2022-05-17       Impact factor: 12.910

4.  Comparative analyses of transgene expression patterns after intra-striatal injections of rAAV2-retro in rats and rhesus monkeys: A light and electron microscopic study.

Authors:  Daniel L Albaugh; Yoland Smith; Adriana Galvan
Journal:  Eur J Neurosci       Date:  2020-11-11       Impact factor: 3.386

Review 5.  Intersectional targeting of defined neural circuits by adeno-associated virus vectors.

Authors:  Chase A Weinholtz; Michael J Castle
Journal:  J Neurosci Res       Date:  2020-12-20       Impact factor: 4.164

6.  Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning.

Authors:  Anna Z Wec; Kathy S Lin; Jamie C Kwasnieski; Sam Sinai; Jeff Gerold; Eric D Kelsic
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

7.  Divergent Whole Brain Projections from the Ventral Midbrain in Macaques.

Authors:  Muhammad Zubair; Sjoerd R Murris; Kaoru Isa; Hirotaka Onoe; Yoshinori Koshimizu; Kenta Kobayashi; Wim Vanduffel; Tadashi Isa
Journal:  Cereb Cortex       Date:  2021-05-10       Impact factor: 5.357

8.  Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno-Associated Viral Vector rAAV9P1.

Authors:  Amelie Bauer; Matteo Puglisi; Dennis Nagl; Joel A Schick; Thomas Werner; Andreas Klingl; Jihad El Andari; Veit Hornung; Horst Kessler; Magdalena Götz; Dirk Grimm; Ruth Brack-Werner
Journal:  Adv Sci (Weinh)       Date:  2022-04-10       Impact factor: 17.521

Review 9.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10

Review 10.  Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses.

Authors:  Ana Fajardo-Serrano; Alberto J Rico; Elvira Roda; Adriana Honrubia; Sandra Arrieta; Goiaz Ariznabarreta; Julia Chocarro; Elena Lorenzo-Ramos; Alvaro Pejenaute; Alfonso Vázquez; José Luis Lanciego
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.